🇺🇸 FDA
Patent

US 8105607

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

granted A61KA61K2039/505A61K2039/5256

Quick answer

US patent 8105607 (Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia) held by The Regents of the University of California expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/505, A61K2039/5256, A61K2039/53, A61K39/00